References
- Carlesimo M, Fidanza L, Mari E, et al. Wells syndrome with multiorgan involvement mimicking hypereosinophilic syndrome. Case Rep Dermatol. 2009;1(1):44–48.
- Melski JW. Wells’ syndrome, insect bites, and eosinophils. Dermatol Clin. 1990;8(2):287–293.
- Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St. John’s Hosp Dermatol Soc. 1971;57(1):46–56.
- Aberer W, Konrad K, Wolff K. Wells’ syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol. 1988;18(1 Pt 1):105–114.
- Coldiron BM, Robinson JK. Low-dose alternate-day prednisone for persistent Wells’ syndrome. Arch Dermatol. 1989;125(12):1625–1626.
- Sinno H, Lacroix JP, Lee J, et al. Diagnosis and management of eosinophilic cellulitis (Wells’ syndrome): a case series and literature review. Can J Plast Surg. 2012;20(2):91–97.
- Herout S, Bauer WM, Schuster C, et al. Eosinophilic cellulitis (Wells syndrome) successfully treated with mepolizumab. JAAD Case Rep. 2018;4(6):548–550.
- Żychowska M, Tutka K, Reich A. Mepolizumab therapy for recalcitrant eosinophilic annular erythema in an adult: a case report and review of treatment options. Dermatol Ther (Heidelb). 2020;10(4):893–899.
- Terhorst-Molawi D, Altrichter S, Röwert J, et al. Effective treatment with mepolizumab in a patient with refractory Wells syndrome. J Dtsch Dermatol Ges. 2020;18(7):737–739.